| Financial Year |
March 31 2023 |
| Monetary Funds |
435,152,569.03 |
| Held-for-trading Financial Assets |
61,003,746.62 |
| Notes Receivable |
1,665,456.75 |
| Accounts Receivable |
201,620,058.32 |
| Advances to Suppliers |
5,629,857.67 |
| Other Receivables |
20,496,650.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,592,167,434.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,824,400.69 |
| Total Current Assets |
2,359,212,920.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
500,874,651.08 |
| Under-construction Projects |
400,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
116,365,232.92 |
| R&D expenses |
-- |
| Goodwill |
1,905,827.33 |
| Long-Term Deferred and Prepaid Expenses |
2,802,400.96 |
| Deferred Income Tax Assets |
14,723,889.98 |
| Other Non-Current Assets |
2,558,564.66 |
| Sub-Total of Non-Current Assets |
653,668,673.66 |
| Total Assets |
3,012,881,593.88 |
| Short-Term Loans |
470,447,708.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
19,585,032.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,987,315.06 |
| Taxes Payable |
21,705,430.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
52,278,965.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,983,977.55 |
| Other Current Liabilities |
2,815,507.43 |
| Sub-Total of Current Liabilities |
602,848,756.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,287,838.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
129,213,634.99 |
| Total Liabilities |
732,062,391.35 |
| Paid-In Capital(Or Share Stock) |
330,951,600.00 |
| Capital Surplus |
834,689,338.39 |
| Surplus Reserve |
132,142,747.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
885,897,062.18 |
| Minority Stockholder's Interest |
97,138,454.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,183,680,747.95 |
| Owner's Equity（Stockholder's Equity） |
2,280,819,202.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,012,881,593.88 |
